Clinical Trial Update: Impact of Patient Support by the Medical Staff on Adherence to Therapy With PegIntron Plus Rebetol (Study P04413)

View source ↗

Summary

Clinical trial update reporting results on whether patient support from medical staff improves adherence to PegIntron (peginterferon alfa-2b) plus Rebetol (riba…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• PegIntron (pegylated interferon alfa-2b)
• Rebetol (ribavirin)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hepatitis C, Chronic Hepatitis C | Status: COMPLETED | Results posted: 2011-04-21